HIV Negative
Showing 1 - 25 of >10,000
Mpox in HIV Negative High Risk Sexual Health Clinic Attenders
Not yet recruiting
- Monkeypox
- HIV Coinfection
- No intervention
- (no location specified)
Jul 19, 2023
Kaposi Sarcoma Trial run by the NCI (Abemaciclib)
Recruiting
- Kaposi Sarcoma
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
Mycobacterial and Opportunistic Infections in HIV-Negative Thai
Active, not recruiting
- Non-Tuberculous Mycobacteria
- +2 more
-
Taiwan, ChinaNational Taiwan University
Aug 18, 2022
Acceptability ofPrEP Program Among MSM and Transgender and
Not yet recruiting
- HIV Infections
- STI
- acceptability of a PrEP program among HIV-negative MSM and TG
- (no location specified)
Jul 10, 2023
Anal High Grade Squamous Intraepithelial Lesion, Anal Precancerous Condition, AIN 2/3 Trial in San Francisco, Chicago, New York
Not yet recruiting
- Anal High Grade Squamous Intraepithelial Lesion
- +5 more
- Artesunate
- Placebo
-
San Francisco, California
- +2 more
Nov 7, 2022
HIV/AIDS Trial in Entebbe (POPPi behavioral intervention)
Completed
- HIV/AIDS
- POPPi behavioral intervention
-
Entebbe, UgandaUganda Virus Research Institute
Mar 21, 2022
HIV Seropositivity, Tuberculosis, Household Contact Trial in Klerksdorp (Daily rifapentine and isoniazid for 4 weeks, Weekly
Not yet recruiting
- HIV Seropositivity
- +2 more
- Daily rifapentine and isoniazid for 4 weeks
- Weekly rifapentine and isoniazid for 12 weeks
-
Klerksdorp, North West Province, South AfricaThe Aurum Institute: Gavin J Churchyard Legacy Centre
Jan 31, 2023
HIV Trial in South Africa, Uganda (Placebo Vaginal Ring, Dapivirine Vaginal Ring, 25 mg)
Completed
- HIV Infections
- Placebo Vaginal Ring
- Dapivirine Vaginal Ring, 25 mg
-
Ladysmith, Kwazulu Natal, South Africa
- +6 more
Jun 14, 2022
Human Immunodeficiency Virus, Human Papillomavirus- 6, 11, 16, 18, Adolescent Trial run by the NCI (Gardasil, Survey)
Completed
- Human Immunodeficiency Virus
- +3 more
- Gardasil
- Survey
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 26, 2022
Transgender Health, Gender Dysphoria, Transgender Women Trial in Philadelphia (Doravirine/Lamivudine/Tenofovir, Spironolactone
Completed
- Transgender Health
- +3 more
- Doravirine/Lamivudine/Tenofovir
- +3 more
-
Philadelphia, PennsylvaniaClinical Research Unit at Thomas Jefferson University
Feb 1, 2023
HIV Negative and Not Yet on PrEP Trial in Los Angeles (PrEP Talk)
Recruiting
- HIV Negative and Not Yet on PrEP
- PrEP Talk
-
Los Angeles, CaliforniaMatt Mutchler
Jul 26, 2022
Tuberculosis Trial (BNT164a1, BNT614b1, Placebo)
Not yet recruiting
- Tuberculosis
- BNT164a1
- +2 more
- (no location specified)
Jan 18, 2023
HIV Trial in Lusaka (HIV self-testing with partner notification.)
Completed
- HIV
- HIV self-testing with partner notification.
-
Lusaka, ZambiaChipata Health Centre
Jun 30, 2021
HIV-infection Trial in Bangkok (Colon biopsy, lymph node biopsy, lumbar puncture)
Recruiting
- HIV-infection
- Colon biopsy, lymph node biopsy, lumbar puncture
-
Bangkok, ThailandThai Red Cross AIDS Research Center
Sep 20, 2021
HIV Trial in Entebbe, Kampala (ALVAC-HIV MN120TMG (vCP205), ALVAC-RG Rabies Glycoprotein (vCP65))
Completed
- HIV Infections
- ALVAC-HIV MN120TMG (vCP205)
- ALVAC-RG Rabies Glycoprotein (vCP65)
-
Entebbe, Uganda
- +1 more
Oct 28, 2021
HIV Trial in Oxford (ChAdOx1.tHIVconsv1 (C1), MVA.tHIVconsv3 (M3), MVA.tHIVconsv4 (M4))
Completed
- HIV
- ChAdOx1.tHIVconsv1 (C1)
- +2 more
-
Oxford, United KingdomCentre for Clinical Vaccinology and Tropical Medicine, Churchill
Aug 10, 2022
HIV, HIV Seronegativity Trial in Baltimore (Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203), Aluminum hydroxide, MF59)
Completed
- HIV Infections
- HIV Seronegativity
- Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203)
- +3 more
-
Baltimore, MarylandJHU AVEG
Oct 27, 2021
Healthy Trial in Oxford (ChAdOx1.HTI and MVA.HTI)
Completed
- Healthy
- ChAdOx1.HTI and MVA.HTI
-
Oxford, United KingdomCentre for Clinical Vaccinology and Tropical Medicine, Churchill
Aug 31, 2022
HIV, HIV Seronegativity Trial in United States (ALVAC-HIV MN120TMG (vCP205))
Completed
- HIV Infections
- HIV Seronegativity
- ALVAC-HIV MN120TMG (vCP205)
-
Birmingham, Alabama
- +5 more
Oct 28, 2021
HIV Trial in United States (ALVAC(2)120(B,MN)GNP (vCP1452), gp160 MN/LAI-2, ALVAC(1)120(B,MN)GNP (vCP1433))
Completed
- HIV Infections
- ALVAC(2)120(B,MN)GNP (vCP1452)
- +4 more
-
Birmingham, Alabama
- +5 more
Oct 27, 2021
HIV, Drug Use, Opioid Use Trial in United States (drug, diagnostic test, other, behavioral)
Enrolling by invitation
- HIV Infections
- +3 more
- Medication for opioid-use disorder (MOUD) for opioid-use disorder (OUD)
- +10 more
-
Los Angeles, California
- +4 more
Aug 30, 2022
Pharmacokinetics, Safety Issues, Bleeding Trial in Portland, Pittsburgh (IPM Ring-105, IPM Ring-106)
Not yet recruiting
- Pharmacokinetics
- +2 more
- IPM Ring-105
- IPM Ring-106
-
Portland, Oregon
- +1 more
Jun 21, 2022
HIV Trial in United States (Indinavir sulfate, Ritonavir, Amprenavir)
Completed
- HIV Infections
- Indinavir sulfate
- +5 more
-
Palo Alto, California
- +7 more
Oct 28, 2021